Cargando…
Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230374/ https://www.ncbi.nlm.nih.gov/pubmed/35744029 http://dx.doi.org/10.3390/medicina58060766 |
| _version_ | 1784735041982562304 |
|---|---|
| author | Aljabali, Ahmed Abdo, Maha Negida, Ahmed |
| author_facet | Aljabali, Ahmed Abdo, Maha Negida, Ahmed |
| author_sort | Aljabali, Ahmed |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9230374 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92303742022-06-25 Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213 Aljabali, Ahmed Abdo, Maha Negida, Ahmed Medicina (Kaunas) Comment MDPI 2022-06-06 /pmc/articles/PMC9230374/ /pubmed/35744029 http://dx.doi.org/10.3390/medicina58060766 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Comment Aljabali, Ahmed Abdo, Maha Negida, Ahmed Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213 |
| title | Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213 |
| title_full | Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213 |
| title_fullStr | Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213 |
| title_full_unstemmed | Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213 |
| title_short | Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213 |
| title_sort | comment on abbas et al. the safety and efficacy of nusinersen in the treatment of spinal muscular atrophy: a systematic review and meta-analysis of randomized controlled trials. medicina 2022, 58, 213 |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230374/ https://www.ncbi.nlm.nih.gov/pubmed/35744029 http://dx.doi.org/10.3390/medicina58060766 |
| work_keys_str_mv | AT aljabaliahmed commentonabbasetalthesafetyandefficacyofnusinerseninthetreatmentofspinalmuscularatrophyasystematicreviewandmetaanalysisofrandomizedcontrolledtrialsmedicina202258213 AT abdomaha commentonabbasetalthesafetyandefficacyofnusinerseninthetreatmentofspinalmuscularatrophyasystematicreviewandmetaanalysisofrandomizedcontrolledtrialsmedicina202258213 AT negidaahmed commentonabbasetalthesafetyandefficacyofnusinerseninthetreatmentofspinalmuscularatrophyasystematicreviewandmetaanalysisofrandomizedcontrolledtrialsmedicina202258213 |